← Eichor
Study identifier: NCT06548061 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

D20054;LITT for Spine Tumors

Condition: Spinal Metastases  ·  Sponsor: Dartmouth-Hitchcock Medical Center

PhaseNA
Planned participants25
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The objective of this clinical study is to evaluate the efficacy and safety of spinal laser interstitial therapy in the treatment of metastatic spinal tumors. The investigators hypothesize that rates of local tumor control are comparable between conventional open surgical techniques and spinal laser interstitial therapy.

This description comes directly from the study's public registry record.

Talk to the study team

Lauren Sinks, MPH  ·  603-650-6380  ·  lauren.j.sinks@hitchcock.org

Always discuss trial participation with your own doctor first.

Locations (1)

Dartmouth HealthLebanon, New Hampshire, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06548061